NCT07097831

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

An Open-label, Single-arm, Fixed-sequence, Single-center Phase I Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Shandong Suncadia Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The study was designed to evaluate the pharmacokinetic effects of rosuvastatin calcium tablets after oral administration of HRS-1301 in healthy subjects.

Conditions

• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	HRS-1301 Tablets	HRS-1301 tablets.
DRUG	Rosuvastatin Calcium Tablets	Rosuvastatin calcium tablets.

Timeline

• Start date: 2025-10-09
• Primary completion: 2025-11-07
• Completion: 2025-11-07
• First posted: 2025-07-31
• Last updated: 2026-01-09

Locations

1 site across 1 country: China